<DOC>
	<DOCNO>NCT00254475</DOCNO>
	<brief_summary>The purpose study provide data dose response simvastatin lower LDL-C co-administered valsartan patient essential hypertension hypercholesterolemia . The primary objective study show combination valsartan 160mg/simvastatin 40mg superior efficacy compare combination valsartan 160mg/simvastatin 20mg percentage change baseline LDL-C .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Valsartan/Simvastatin Combinations Patients With Both Essential Hypertension Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Elevated LDLCholesterol Essential hypertension Severe Hypertension Prior know muscular neuromuscular disease type A history cardiovascular disease Hypertension hypercholesterolemia due secondary cause Uncontrolled diabetes insulin treatment Evidence hepatic renal disease Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Valsartan</keyword>
	<keyword>simvastatin</keyword>
	<keyword>hypertension</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>angiotensin II receptor blocker</keyword>
</DOC>